The San Diego facility will support further developing Vividion's global research and clinical portfolio and pave the way for future programs to deliver best-in-class...

Bayer and Charité - Universitätsmedizin Berlin recently unveiled plans to establish the Berlin Center for Gene and Cell Therapies, a translational center for gene and...

A growing and aging world population and the increasing strain on nature’s ecosystems are among the major challenges facing humanity.

Bayer and RTW Investments have announced an equity investment in Jixing Pharmaceuticals of €32 million ($35 million) and €116 million ($127 million) respectively.

Fluor Corporation announced today that it has completed construction of Bayer’s first global Cell Therapy Launch Facility in Berkeley, California. Completion was...

Bayer’ Crop Science division plans to invest €220 million in a new research and development (R&D) facility at its Monheim, Germany site. This is the company’s largest...

Heike Prinz will join the Bayer Board of Management as Chief Talent Officer and Labor Director effective Sept. 1, 2023.

Bayer and Peking University (PKU) to collaborate on enhancing the translation of fundamental pharmaceutical research into state-of-the-art technologies throughout the...

CEO Werner Baumann may be headed for an early exit from Bayer, Bloomberg reports.

After months of anticipation, the US Supreme Court has deflated Bayer’s hopes that the court’s conservative majority would vote to hear its appeal to overturn a $25...

Bayer has won its fourth consecutive appeal of a US court case previously decided in favor of a plaintiff who claimed that Monsanto’s glyphosate-based Roundup herbicide...